Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.75 |
| ▸ | DEGS1 | O15121 | 2/20 | 0.74 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.64 |
| ▸ | CETP | P11597 | 4/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | FAAH | O00519 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.49 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6657556 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL7897402 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL6657795 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL6658369 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL21660329 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL22910990 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL21581283 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL22911004 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL21581286 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL21428456 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110077309-A1 | HUMECTANT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-31 | — | — | US | claimed |
| US-20240197610-A1 | CERAMIDE GROWTH PROMOTING AGENT | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2024-06-20 | — | — | US | disclosed |
| EP-4119196-A1 | CERAMIDE GROWTH PROMOTING AGENT | Takasago International Corporation (JP) | 2023-01-18 | — | — | EP | disclosed |
| CN-115243666-A | Ceramide proliferation promoter | 高砂香料工业株式会社 | 2022-10-25 | — | — | CN | disclosed |
| EP-1633313-B1 | LIPID COMPOSITION AND SKIN CARE FORMULATION CONTAINING THE SAME | TAKASAGO PERFUMERY CO LTD (JP) | 2016-12-07 | — | — | EP | disclosed |
| US-8865191-B2 | Lipid composition and skin care formulation containing the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-10-21 | — | — | US | disclosed |
| US-8313755-B2 | Long-chain fatty acid having 12 to 24 carbon atoms, a nonionic surface active agent; cosmetics, bath agents, hair-care products, external preparations for the skin | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-11-20 | — | — | US | disclosed |
| EP-1153595-B1 | Clear aqueous ceramide composition | TAKASAGO PERFUMERY CO LTD (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20110077309-A1 | HUMECTANT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-31 | — | — | US | disclosed |
| EP-1946743-A2 | Humectant Composition | Takasago International Corporation (JP) | 2008-07-23 | — | — | EP | disclosed |
| US-20080171794-A1 | HUMECTANT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-07-17 | — | — | US | disclosed |
| US-20060210522-A1 | Lipid composition and skin care formulation containing the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-09-21 | — | — | US | disclosed |
| EP-1633313-A1 | LIPID COMPOSITION AND SKIN CARE FORMULATION CONTAINING THE SAME | Takasago International Corporation (JP) | 2006-03-15 | — | — | EP | disclosed |
| WO-2004098557-A1 | LIPID COMPOSITION AND SKIN CARE FORMULATION CONTAINING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (FR) | 2004-11-18 | — | — | WO | disclosed |
| US-20020010215-A1 | Clear aqueous ceramide composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-01-24 | — | — | US | disclosed |
| EP-1153595-A2 | Clear aqueous ceramide composition | Takasago International Corporation (JP) | 2001-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060210522-A1 | Lipid composition and skin care formulation containing the same | CERT1, SGMS1, CERS2 | MEN1 2333/4885KMT2A 3033/4885ASAH1 13/4885 |
| US-20240197610-A1 | CERAMIDE GROWTH PROMOTING AGENT | SGMS1, CERT1, SGMS2 | MEN1 867/4885KMT2A 2813/4885ASAH1 27/4885 |
| US-20110077309-A1 | HUMECTANT COMPOSITION | HSPH1, HOGA1, HMOX2 | MEN1 3367/4885KMT2A 3617/4885ASAH1 197/4885 |
| US-20020010215-A1 | Clear aqueous ceramide composition | CERS2, CERT1, SGMS1 | MEN1 3473/4885KMT2A 3379/4885ASAH1 7/4885 |
| US-20080171794-A1 | HUMECTANT COMPOSITION | HSPH1, HOGA1, HMOX2 | MEN1 3367/4885KMT2A 3617/4885ASAH1 197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.